Anatara Lifesciences (ASX:ANR)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Anatara Lifesciences.
RELATED STOCKHEAD STORIES
Top 10 at 11: ASX roars to life, surging 1pc on resources and real estate strength
Lunch Wrap: ASX on the front foot despite a Powell googly; gold hits record again
Lunch Wrap: ASX rebounds; DigiCo REIT and Capstone Copper earn spots in ASX 200
Closing Bell: ASX sinks as soft earnings melt hopes; Fortescue and Magellan hit hard
Health Check: Joy as Mesoblast wins its first FDA approval for a stem-cell therapy after decades of trying
Health Check: Hearts are pumping as Anteris shares debut on the Nasdaq
Health Check: ‘Cannabis corner’ in the green with record revenues and favourable deals
Market Highlights: US GDP boosts market confidence, and 5 ASX small caps to watch today
Rise and Shine: Everything you need to know before the ASX opens
ASX Health Stocks: AVITA flies as high as 24pc after providing a big, bullish guidance
10 at 11ish: MC Mining bounces on takeover bid, Block rockets
Rise and Shine: Everything you need to know before the ASX opens
Closing Bell: Benchmark ends an ordinary Monday on a low, despite Dacian’s big gold delivery
